Sharechat Logo

Lloyd Morrison goes on Infratil buying spree

Friday 16th March 2001

Text too small?
LLOYD MORRISON: Builds his stake in Infratil
By Nicholas Bryant

Infratil New Zealand founder Lloyd Morrison has put his money where his mouth is and become a substantial security holder in the company.

A longtime critic of financial institutions he claims have continuously undervalued Infratil, Mr Morrison and his business associate, Liberato Petana, have crossed the 5% substantial security holder threshold using their private company Hettinger Nominees.

Infratil's 2000 annual report shows Hettinger Nominees own 935,000 shares, only 0.5% of those on issue.

But a recent notice to the Stock Exchange shows Hettinger went on a 10.6 million-share buying spree between November 24, 2000 and January 24 this year.

Hettinger now owns 11.5 million shares for a 6.2% stake of issued stock.

The shares cost $1.18-$1.25 each.

Mr Morrison said the purchases reflected a greater focus by him and Infratil's management company Morrison & Co on Infratil New Zealand.

Last year Infratil Australia was taken over by Hastings Funds Management, while analysts are tipping Utilico, formerly Inftratil International, to be wound up.

The company has already repaid 40%of invested capital.

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report